Some small trials have explored low-dose naltrexone (LDN) alongside semaglutide or other GLP-1 medications, with preliminary findings suggesting additive weight loss benefits in select populations
Some patients report symptom improvement with anti-inflammatory diets, though evidence is limited
GLP-1RAs also inhibited inflammatory signaling, contributing to their analgesic efficacy in neuropathic pain, particularly in chronic pain [64, 69]
Months 618: Optimization and Maintenance As you approach your goal weight, we adjust your treatment plan for long-term sustainability
Muscle Preservation Focus Strategies to protect lean muscle while you lose fat
Portion Control: With Semaglutide GLP-1 potentially reducing appetite, its vital to listen to your bodys hunger cues to avoid overeating